Future management of CTCL

Evangelina Papadavid, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, discusses the future of management of cutaneous T-cell lymphoma (CTCL), commenting on differences in the treatment of early- and late-stage disease. Prof. Papadavid comments on the use of topical treatments in early treatment and the use of systemic treatments in later-stage disease or patients with poor prognosis. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.